Speakers

Wissam Baghdadi

Engineer Process Development • Sangamo Therapeutics

Wissam Baghdadi is Sangamo’s Engineer in Process Development, and in this role he develops manufacturing processes for Sangamo’s cell therapies using gene edited regulatory T cells, or Tregs. He is notably in charge of optimizing cell purity, quality, and quantity. Wissam notably played a key role in developing Sangamo’s proprietary CAR-Treg manufacturing process used in the first-in-human STEADFAST clinical study. He is also closely involved in the transfer of Sangamo’s processes to manufacturing teams, both internally and externally.

Wissam has been with Sangamo Therapeutics France – formerly known as TxCell prior to its acquisition by Sangamo in 2018 – since 2014.

Also Speaking

Steven B. Miller

Farzin Farzaneh

Chief Scientific Officer • ViroCell Biologics

Samik Upadhaya

Assistant Director of Scientific Affairs • Cancer Research Institute

Also Speaking

Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.
Image

Briefings

Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.